Ask AI

Grooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction

Learn how to develop individualized, guideline-concordant treatment plans for patients with dyslipidemia that thoroughly address their atherosclerotic cardiovascular disease risk, including how to use Lp(a) as an alternative biomarker when taking LDL-C into account, through expert-written ClinicalThought commentaries, downloadable slides, and an on-demand webcast.

Share

Program Content

Events

Activities

New rhythm in hyperlipidemia care
Finding a New Rhythm in Hyperlipidemia Care: The Future of Lipid Management and ASCVD Prevention
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 18, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation